Sustained Release Excipients Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Sustained Release Excipients Market?
In recent times, the market size of sustained release excipients has expanded significantly. Its growth projection starts from $1.4 billion in 2024 and is supposed to reach $1.53 billion by 2025, growing at a compound annual growth rate (CAGR) of 9.1%. The growth witnessed during the historical period is reportedly due to heightened demand for controlled drug release, the prevalence of chronic diseases, patient adherence and ease of use, innovative strides in the pharmaceutical industry, as well as regulatory support for extended-release formulations.
What Growth Rate Is Forecasted for the Sustained Release Excipients Market by 2029?
In the coming years, the market for sustained release excipients is projected to experience robust growth, reaching a size of “$2.13 billion by 2029 with a compound annual growth rate (CAGR) of 8.8%. This growth within the forecast period is largely attributable to factors such as a growing elderly population, emphasis on personalized medicine, challenges linked to patient adherence, escalating intricate drug formulations, advancements in managing diseases, and the worldwide expansion of healthcare. The major trends anticipated during the forecast period involve patient-focused drug delivery, partnerships for developing formulations, compliance with regulations and safety, worldwide growth of drug formulation technologies, and the impact of biopharmaceuticals.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp
Which Key Companies Are Shaping the Future of the Sustained Release Excipients Market?
Major companies operating in the sustained release excipients market include BASF SE, Ashland Global Holdings Inc., Colorcon Inc., Croda International Plc, Dow Chemical Company, DuPont de Nemours Inc., Roquette Frères, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, JRS Pharma GmbH & Co. KG, Shin-Etsu Chemical Co.Ltd., Gattefossé SAS, Eastman Chemical Company, Cellulose Solutions Private Limited, Avantor Inc., SPI Pharma Inc., Asahi Kasei Corporation, Chemische Fabrik Budenheim KG, Associated British Foods plc, Ransom Naturals Ltd, Balchem Corporation, IMCD Group, Lonza Group AG
Which Factors Are Driving Demand in the Sustained Release Excipients Industry?
The rise in chronic and acute illnesses is anticipated to fuel the expansion of the sustained-release excipients market. Chronic and acute illnesses differ based on their duration and development, with the former lasting long periods, typically over three months, and the latter being severe but brief, only lasting a few hours to weeks. The broad application of sustained-release excipients to formulate drugs for these disease types has contributed to market growth. This is due to their ability to enhance patient compliance, maintain stable drug concentrations, lessen adverse effects, and optimize disease control. The World Health Organization reported in September 2022 for example that cardiovascular diseases, causing 17.9 million deaths annually, were the leading NCD killer, followed by chronic respiratory diseases (4.1 million), diabetes (2.0 million, which includes deaths from kidney disease caused by diabetes), and cancer (9.3 million). Moreover, a report from the American College of Cardiology in August 2022 projected that the main four cardiovascular risk factors would rise from 2025 to 2060 in the United States. The sharpest increase is predicted in diabetes, with a 39.3% hike to 55 million people, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Additionally, significant escalations in cardiovascular disease rates are expected for stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), with ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) trailing closely. Consequently, the escalating occurrence of chronic and acute illnesses propels the advancement of the sustained-release excipients market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=10822&type=smp
How Is the Sustained Release Excipients Market Segmented by Several Divisions?
The sustained release excipients market covered in this report is segmented –
1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan
2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation
Subsegments:
1) By Gelatin: Type A Gelatin, Type B Gelatin
2) By Polymers: Natural Polymers, Synthetic Polymers
3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients
4) By Sugars: Sucrose, Lactose, Glucose, Other Sugars
5) By Alcohol: Ethanol, Isopropyl Alcohol, Other Alcohols
6) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan
What are the Emerging Market Trends Driving the Growth of the Sustained Release Excipients Industry?
The trend of product innovation is becoming increasingly prevalent in the sustained release excipients market. Key players in the market are focused on creating innovative products to solidify their market presence. For example, Nutriventia Limited, a pharmaceutical company located in India, rolled out a novel product called Prolanza in September 2022. This is a sustained-release ashwagandha ingredient (Withania somnifera) that provides long-lasting support for stress reduction. Thanks to its unique delivery system, Prolanza exhibits therapeutic benefits for an elongated period with just one daily dosage. The ashwagandha in Prolanza showed superior absorption rates and bioavailability, and a prolonged elimination half-life compared to the control substance, underlining its sustained-release properties. With ashwagandha known for its adaptogen capabilities and stress response reduction, Prolanza’s therapeutic effects are long-lasting and beneficial for overall health. Made from natural herbs, its efficacy has been clinically verified.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report
Which Regions Are Driving Growth in the Sustained Release Excipients Market?
North America was the largest region in the global sustained release excipients market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10822
This Report Delivers Insight On:
1. How big is the sustained release excipients market, and how is it changing globally?
2. Who are the major companies in the sustained release excipients market, and how are they performing?
3. What are the key opportunities and risks in the sustained release excipients market right now?
4. Which products or customer segments are growing the most in the sustained release excipients market?
5. What factors are helping or slowing down the growth of the sustained release excipients market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
